Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Miguel Ángel Macías-Islas"'
Autor:
Gabriela del Carmen López-Armas, Martha Eloisa Ramos-Márquez, Mónica Navarro-Meza, Miguel Ángel Macías-Islas, Ana Miriam Saldaña-Cruz, Abraham Zepeda-Moreno, Fernando Siller-López, José Alfonso Cruz-Ramos
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 2, p 916 (2023)
Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease that affects the nervous system. Peripheral blood leukocyte telomere length (LTL) and mitochondrial DNA copy number (mtDNA-CN) are potential biomarkers of neurological disability an
Externí odkaz:
https://doaj.org/article/3d061c188b584d35aaf62955a075214a
Autor:
Verónica Loera-Castañeda, Lucila Sandoval-Ramírez, Fermín Paul Pacheco Moisés, Miguel Ángel Macías-Islas, Moisés Alejandro Alatorre Jiménez, Erika Daniela González-Renovato, Fernando Cortés-Enríquez, Alfredo Célis de la Rosa, Irma E. Velázquez-Brizuela, Genaro Gabriel Ortiz
Publikováno v:
International Journal of Alzheimer's Disease, Vol 2014 (2014)
Mitochondrial dysfunction has been thought to contribute to Alzheimer disease (AD) pathogenesis through the accumulation of mitochondrial DNA mutations and net production of reactive oxygen species (ROS). Mitochondrial cytochrome c-oxidase plays a ke
Externí odkaz:
https://doaj.org/article/91388a49bb4440a99a586d2ee8a6233a
Autor:
Adriana Carrá, Miguel Ángel Macías-Islas, Alberto Alan Gabbai, Jorge Correale, Carlos Bolaña, Eduardo Duriez Sotelo, Juan García Bonitto, Fernando Vergara-Edwards, Darwin Vizcarra-Escobar
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 4 (2011)
Objective : The prevalence of multiple sclerosis (MS) in Latin America varies across different studies but an intermediate risk and increased frequency of the disease have been reported in recent years. The circumstances of Latin American countries a
Externí odkaz:
https://doaj.org/article/262e59b8d6864c36846531db3e9efce3
Autor:
David Vázquez-Vázquez, Andrés Palomera-Chávez, Aniel Jessica Leticia Brambila-Tapia, José Luis Ruiz-Sandoval, Miguel Ángel Macías-Islas, Juan Francisco Ramírez-Martínez, Mario A. Mireles-Ramírez, Maria Margarita Gutiérrez-García, Rosa Martha Meda-Lara, Andrea Dayanara De-Santos-Fonseca
Publikováno v:
EXPLORE. 18:88-95
Background To date, no studies have used hypnosis to examine and manage the potential emotional causes of multiple sclerosis (MS) in the scientific field; therefore, we decided to compare the effectiveness of hypnoanalysis and guided imagery for dete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f44806a6b90947fa1420b4ac87390f75
https://doi.org/10.1016/j.explore.2020.10.002
https://doi.org/10.1016/j.explore.2020.10.002
Autor:
Eduardo Ignacio Díaz-Barba, Alejandra Martínez-Hernández, Ana Miriam Saldaña-Cruz, Martha Eloísa Ramos-Márquez, Abraham Zepeda-Moreno, J. A. Cruz-Ramos, Mónica Navarro-Meza, Héctor Raúl Pérez-Gómez, Gabriela Lopez-Armas, Miguel Ángel Macías-Islas
Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease that affects the nervous system. Peripheral blood leukocyte telomere length (LTL) and mitochondrial DNA copy number (mtDNA-CN) are potential biomarkers of disability and neurologica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6230876812ac2533ff485775118d57bd
Autor:
José Francisco Muñoz-Valle, Xochil Trujillo, Miguel Ángel Macías-Islas, Baltazar-Rodríguez Luz Margarita, Miguel Huerta, Mario A. Mireles-Ramírez, Emmanuel Valdés-Alvarado, Jorge Gutierrez, Yeminia Valle
Publikováno v:
Disease Markers, Vol 2019 (2019)
Disease Markers
Disease Markers
Introduction. Multiple sclerosis is an inflammatory disease, where fibrin deposition and the impairment in its degradation have been shown to play an important role in the demyelination process. Tissue plasminogen activator (tPA) is a serine protease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7df508d7cfc44d5101d8ad41981ceb55
https://doi.org/10.1155/2019/9626289
https://doi.org/10.1155/2019/9626289
Autor:
Manuel Mejía, Diana P. Portales-Pérez, Ildefonso Rodriguez-Leyva, Fernando Cortés-Enríquez, Miguel Ángel Macías-Islas, Erika Chi-Ahumada, María E. Jiménez-Capdeville
Publikováno v:
Journal of the Neurological Sciences. 396:87-93
The protein alpha-synuclein (α-Syn) has been linked to neuroinflammatory conditions. We investigated whether the presence of α-Syn in peripheral tissues is a surrogate of brain inflammatory status in a small group of relapsing-remitting multiple sc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db971b3f770237384d71b8a161d4db02
https://doi.org/10.1016/j.jns.2018.11.003
https://doi.org/10.1016/j.jns.2018.11.003
Autor:
Sandra Quiñones-Aguilar, Verónica Rivas-Alonso, Gloria de Lourdes Llamosa García Velázquez, Marco Antonio Santos-Diaz, José Flores-Rivera, Victor Gonzalez-Amezquita, Manuel De la Maza-Flores, Carolina León-Jiménez, Zaira Medina-López, Miguel Ángel Macías-Islas, Brenda Bertado-Cortés, Laura Ordoñez-Boschetti, Eli Skromne-Eisenberg, Irene Treviño-Frenk, Jair Fernando Ortiz-Maldonado, Leonardo Llamas-López
Publikováno v:
Multiple sclerosis and related disorders. 53
Background Multiple sclerosis affects more than 2 million people. Clinical decisions are performed under evidence-based medicine. The appearance of new disease-modifying therapies and changes in diagnostic criteria complicates the decision-making pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f4daa68016daeb014ddaf0ed55e15b1
https://pubmed.ncbi.nlm.nih.gov/34139461
https://pubmed.ncbi.nlm.nih.gov/34139461
Autor:
Diego Rivera, Daniela Ramos Usuga, Eliana María Fuentes Mendoza, Adriana Aguayo Arelis, Brenda Viridiana Rabago Barajas, Miguel Ángel Macías Islas, Denise Krch, Anthony H. Lequerica, Juan Carlos Arango-Lasprilla
Publikováno v:
Multiple Sclerosis and Related Disorders. 59:103685
Between 50-60% of Multiple Sclerosis (MS) patients have cognitive alterations. There are several batteries to assess cognitive impairments in MS, however, few exist for Latin Americans. The objective of this study is to evaluate the neuropsychologica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdeda212aa2a40a2651ba0004d8de49d
https://doi.org/10.1016/j.msard.2022.103685
https://doi.org/10.1016/j.msard.2022.103685
Autor:
U. De la Cruz-Mosso, O. Padilla-De la Torre, J.L. Ruiz-Sandoval, Daniel Ortuño-Sahagún, Norma Torres-Carrillo, Miguel Huerta, Oscar Gonzalez-Perez, Xóchitl Trujillo, Víctor Andrés Castañeda-Moreno, José Francisco Muñoz-Valle, Miguel Ángel Macías-Islas, Mario A. Mireles-Ramírez
Publikováno v:
Journal of Neuroimmunology. 320:117-124
Macrophage migration inhibitory factor (MIF) is a cytokine associated with tissue damage in multiple autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis and psoriatic arthritis. The role of MIF in multiple sclerosis (MS) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7af6caa1395eea50d9fec3c724d1bc4d
https://doi.org/10.1016/j.jneuroim.2018.04.006
https://doi.org/10.1016/j.jneuroim.2018.04.006